Stifel Reiterates Buy Rating on NOV Inc. (NOV)

Stifel analyst Stephen Gengaro reiterated a Buy rating and $23.00 price target on NOV Inc. (NYSE: NOV).

The analyst commented, "We believe NOV's 1Q25 results and outlook are about neutral for NOV shares. Keys include: 1) 1Q25 adjusted EBITDA of $252 million beat our forecast by 4.3% and exceeded the $248.1 million consensus; 2) midpoint of 2Q25 EBITDA guidance of $250-280 million is close to our $266.5 million forecast, and captures the $277.8 million consensus; 3) posted a book-to-bill of 80%, and the macro backdrop could create an order headwind; 4) delivered $51 million in FCF, easily exceeding the ($8.1) million consensus; and 5) returned $109 million in capital to its shareholders, and continues to expect to return 50% of its excess FCF to shareholders on an annual basis."

For an analyst ratings summary and ratings history on NOV Inc. click here. For more ratings news on NOV Inc. click here.

Shares of NOV Inc. closed at $12.24 yesterday.

You May Also Be Interested In

• Wolfe Research Upgrades American Tower (AMT) to Outperform
• BMO Capital Starts Align Technology (ALGN) at Outperform
• Stifel Reiterates Buy Rating on Ondas Holdings (ONDS) following DZYNE Technologies deal